- Description
- Additional Information
- Readable Documents
- Assay Principle
- Reviews
Key Benefits
- Homogenous assay for active caspase 3/7.
- Breakthrough in cell lysis buffer and preservation of caspase activity.
- Results in a no-wash, one-step assay.
- No need to wash out media from cell samples, just add the reagent directly to your experimental samples.
- Easy to Use: No need to make cell lysates or run Western blots.
- Works with suspension and adherent cells.
Additional information
Kit Size | 100, 500, 1000 |
---|
Cell Technology’s APO 3/7 HTS Assay utilizes the quenched (z-DEVD)2-R110 peptide substrate for caspase 3/7 detection. The absorption and emission properties of the R110 dye are suppressed when attached to the z-DEVD peptide sequence. When R110 is cleaved away, by active caspase3/7, form the quenching DEVD sequence, the free dye excites at 488nm and emits at 515-530 nm. As a result of a novel and proprietary Lysis Buffer System, the APO 3/7 HTS Assay is a homogenous platform that can be utilized for high throughput fluorescence plate reader applications. The reagent is directly added to the samples thus eliminating any wash steps.
Figure. In this figure, Jurkat cells were stimulated with various concentrations of staurosporine for 3 hours, after which caspase 3/7 activity was analyzed using the APO 3/7 HTS kit.
Document Title |
Apo3HTSprotocol |
APO 3 HTS Datasheet |
msds.APO3HTS |
Reference |
Slee, E. A., C. Adrain, and S. J. Martin. 1999. Serial Killers: ordering caspase activation events in apoptosis. Cell Death and Differ. 6:1067-1074. |
Walker, N. P., R. V. Talanian, K. D. Brady, L. C. Dang, N. J. Bump, C. R. Ferenz, S. Franklin, T. Ghayur, M. C. Hackett and L. D.Hammill. 1994. Crystal Structure of the Cysteine Protease Interleukin-1ß-Converting Enzyme: A (p20/p10)2 Homodimer. Cell 78:343-352. |
Wilson, K. P., J. F. Black, J. A. Thomson, E. E. Kim, J. P. Griffith, M. A.Navia, M. A. Murcko, S. P. Chambers, R. A. Aldape, S. A. Raybuck, and D. J.Livingston. 1994. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370: 270-275. |
Rotonda, J., D. W. Nicholson, K. M. Fazil, M. Gallant, Y. Gareau, M. Labelle,E. P. Peterson, D. M. Rasper, R. Ruel, J. P. Vaillancourt, N.A. Thornberry and J.W. Becker. 1996. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Struct. Biol. 3(7): 619-625. |
Kumar, S. 1999. Mechanisms mediating caspase activation in cell death. Cell Death and Differ. 6: 1060-1066. |
Alnemri, E.S. et al (1996) Cell 87:171 |
Trends Biochem Sci 22,388 (1997) |
Part# | Reagent | Temperature |
Part# 4004 | Caspase 3/7 Reagent (z-DEVD) 2 Rodamine 110, 1 Vial | -20C |
Part# 3005 | Cell Lysis Buffer, 1 Bottle | 2-8C |
ebiomall.com
>
>
>
>
>
>
>
>
>
>
本人使用的Collagen是sigma公司的,TypeI,BovineCollagenSolution,浓度为6mg/ml,用浓度为1M的NaOH溶液进行中和。200微升Collagen用了30微升的NaOH溶液,在调PH过程中有絮状物质产生并有局部凝胶,然后将调好PH的Collagen放至细胞培养箱中进行培养,2个小时之后也没有凝胶。是NaOH溶液加多了还是没有搅拌均匀,现在还在摸索阶段,不知道具体该加多少NaOH,还有如何将溶液混合均匀是个问题。求大神指导
如磷脂含P,维生素D含N.脂肪只含C、H、O三种元素.
向左转|向右转
小白一枚,现在要构建紫杉醇细胞耐药株。但是我们实验室紫杉醇是医用注射液,浓度为6mg/ml。这个浓度太大了,工作液浓度都是几十ng/ml。想问一下各位大神该如何配置成浓度相对低一点的储存液呢,有效期可以有多久呢?